Michael Jebsen, the CFO (and the former interim CEO) was awarded 79,546 shares at $1.32 on October 1st
Michael Jegsen was warded this huge chunk of shares at the dirt low price of $1.32 JUST before all the crazy PR about $600 million and commercialization of new drug. They just didn't say it has to be tested first and it would take 3 years before the FDA reviews the Phase 3 trials to give an opinion: Yup 3 years.
This CSMITH and the CHURCH guy really did major damage to newbies and suckered them in.
IF FDA approves and that is 2.5 years away before they have the data and they take 6 months to make any decision if not longer. So, why gamble your money for 3 years going no where but down. Why do you think people are selling? This stock was at $1.36 on October 1st when they gave stock to the interim CEO. Then a couple of weeks later they give the PR about $600 million market for the drug when in the entire Europe sales are only $60 million after 10 years of marketing it there.
Please people beware of this poster as he will suck you in and really is the arm of Press Release to pump this stock that was $1.36 on October 1st. Please, don't touch this stock.
Just a warning about this guy.
If you listen to this old fart talking in his retirement with nothing better to do, you will lose your shirt. Notice after he posted this ADVICE and suggesting to by OXBT it has fallen a further -5% this morning.
Once he sold, that is when to buy.
Look for crash to $4.60
I already called their investor relations and they mean roughly JUNE 2014!!!!
Wow, you really go t it wrong. Look at at what you are writing. This is for 3rd Quarter of 2014!!!!